| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 08/04/2005 | US20050171156 Prodrugs of potassium channel inhibitors |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/04/2005 | US20050171089 Bengamide derivatives, process for preparing them, and their use |
| 08/04/2005 | US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/03/2005 | EP1558577A2 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1649594A Process for the preparation of benazepril hydrochloride |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 08/02/2005 | CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 07/28/2005 | WO2005068643A2 Biochemical synthesis of 6-amino caproic acid |
| 07/28/2005 | WO2005037795A3 Substituted spirobenzazepines |
| 07/28/2005 | US20050165089 Compounds, compositions and methods |
| 07/28/2005 | US20050165004 Bronchorelaxing compounds |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1556335A1 Bis-alkylbenzylamines |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066134A1 Bis-dicarboxylic acid salts of benazepril and preparation of benazepril via these salts |
| 07/21/2005 | WO2005066133A2 NOVEL PROCESS FOR PREPARATION OF 10-OXO-10, 11-DIHYDRO-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE (OXCARBAZEPINE) VIA INTERMEDIATE, 10-METHOXY-5H-DIBENZ[b,f] AZEPINE-5-CARBONYLCHLORIDE |
| 07/21/2005 | WO2005066123A1 Protease inhibitors |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2550515A1 Protease inhibitors |
| 07/20/2005 | EP1554250A1 Novel lactams and uses thereof |
| 07/20/2005 | EP1554243A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | CN1642535A Tuberculosis treatment using pleuromutilin derivatives |
| 07/19/2005 | US6919450 Process for the preparation of benazepril |
| 07/14/2005 | WO2005037785A3 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | DE10358004A1 Ketolactam-Verbindungen und ihre Verwendung -Keto lactam compounds and their use |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551808A1 ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ b,f AZEPINE-5-CARBOXAMIDE AND NEW CRYSTAL FORMS THEREOF |
| 07/13/2005 | CN1639151A Novel azepane derivatives |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210032C Parenteral formulations comprising carbamazepine or its derivatives |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/07/2005 | US20050148672 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis |
| 07/07/2005 | US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof |
| 07/06/2005 | EP1549685A1 Novel nitrosation polymer in organic synthesis |
| 07/06/2005 | CN1636011A Succinoylamino lactams as inhibitors and as a beta protein production |
| 07/06/2005 | CN1635999A Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups |
| 07/05/2005 | US6914140 Asymmetric synthesis process |
| 06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
| 06/30/2005 | WO2005058328A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 06/30/2005 | WO2005035504A3 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 06/30/2005 | WO2004089890A3 Process and intermediates for preparing benzazepines |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143319 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome |
| 06/30/2005 | CA2550053A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/28/2005 | US6911458 Compounds |
| 06/23/2005 | WO2005056546A1 Keto lactam compounds and use thereof |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137186 Tetrahydrobenzazepines and their use |
| 06/23/2005 | CA2548276A1 Keto lactam compounds and use thereof |
| 06/22/2005 | EP1542687A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1629143A Process for extracting and separating caprolactam from amide oil |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/21/2005 | CA2159491C Fuel compositions |
| 06/16/2005 | WO2005054190A1 3-aminopyrrolidone derivatives |
| 06/16/2005 | WO2005053702A2 Anti-inflammatory agents |
| 06/16/2005 | WO1990000853A8 Method of treating neurological disorders |
| 06/16/2005 | US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 06/16/2005 | US20050130956 1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof |
| 06/16/2005 | CA2547651A1 Anti-inflammatory agents |
| 06/16/2005 | CA2546653A1 3-aminopyrrolidone derivatives |
| 06/15/2005 | EP1539704A1 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 06/15/2005 | EP1539178A2 Protease inhibitors |
| 06/15/2005 | EP0975608B1 Halo-alkoxycarbonyl prodrugs |
| 06/15/2005 | CN1206161C Process for treating mixture comprising ammonium sulfate solution and aqueous lactam phase |
| 06/14/2005 | US6906192 Processes for the preparation of acid derivatives useful as serine protease inhibitors |
| 06/14/2005 | US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal |
| 06/09/2005 | WO2005051916A1 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics |
| 06/09/2005 | WO2005051399A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 06/09/2005 | WO2005051398A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 06/09/2005 | WO2005051397A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 06/09/2005 | US20050124652 Guanidino compounds |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | CA2547444A1 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics |
| 06/08/2005 | CN1625551A Manufacturing method of 6-aminomethyl-6, 11-dihydro-5H-dibenzo.[b, e] azepine |
| 06/02/2005 | US20050119432 Photo radical generator, photo sensitive resin composition and article |
| 06/01/2005 | EP1536496A1 Organic light emitting device |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534678A1 Pleuromutilin derivatives as antimicrobbials |
| 06/01/2005 | EP1534293A1 Anti-inflammatory compositions and methods of use |
| 06/01/2005 | CN1622809A Orodispersible pharmaceutical composition comprising ivabradine |
| 06/01/2005 | CN1621405A Process for preparing caprolactam by cyclohexanone-oxime gas phase rearrangement |
| 06/01/2005 | CN1204119C Method for separating ammonia from solutions contg. caprolactam and ammonia |
| 05/31/2005 | US6900213 Controlling fertility; contraceptives; anticancer agents |
| 05/31/2005 | US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome |
| 05/26/2005 | WO2005047182A1 High silica cds-1 zeolite |
| 05/26/2005 | US20050113566 Inhibitors of C-FMS kinase |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |